株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

冠動脈ステントの世界市場:成長、動向、予測(2019~2024年)

Coronary Stent Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 802335
出版日 ページ情報 英文 118 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.51円で換算しております。
冠動脈ステントの世界市場:成長、動向、予測(2019~2024年) Coronary Stent Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年02月01日 ページ情報: 英文 118 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

冠動脈疾患の罹患率は、温度を含めた低~中所得の国において過去30年で大きく増加しています。冠動脈ステント市場は、冠動脈疾患の罹患率上昇、高齢化、ステント技術の進歩などにより成長が促進されています。

当レポートでは、世界の冠動脈ステント市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場動向

  • 市場概要
  • 市場促進因子
    • 冠動脈疾患の罹患率上昇
    • 高齢化
    • 冠動脈ステントの技術進歩
  • 市場阻害因子
    • 製品リコールの高さ
    • 厳しい認可プロセス
  • ポーターズファイブフォース分析

第5章 市場セグメンテーション

  • 製品別
    • 薬剤溶出ステント
    • ベアメタルステント
    • バイオアブソーバブルステント
  • バイオマテリアル別
    • メタリック
    • ポリマー
    • 天然
  • エンドユーザー別
    • 病院
    • 外来外科センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合環境

  • 企業プロファイル
    • Abbott Laboratories
    • B. Braun Medical Inc.
    • Biosensors International Group, Ltd.
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • IRIDEX Corporation
    • Medtronic PLC
    • テルモ株式会社
    • Translumina GmbH

第7章 市場の機会と将来動向

目次
Product Code: 64418

Market Overview

The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.

The prevalence of coronary artery disease (CAD) has increased in the past three decades in the low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus the burden of CAD has increased and has boosted the usage of coronary stents, thus helping in driving the market growth. In addition, the increasing geriatric population has also increased the demand for coronary stents that is expected to rise over the forecast period.

There has also been a high demand for minimally invasive surgical procedures that is likely to significantly drive the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.

Scope of the Report

As per the scope of the report, coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.

Key Market Trends

Drug-eluting Stent is the Largest Segment by Product Type that is Expected to Grow during the Forecast Period

The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.

North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period

North America holds the largest market share for coronary stents, due to the dominance of the top companies present in the global market. There is also an increase in the ageing population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market.

Competitive Landscape

The major companies have adopted strategies like mergers and acquisitions and strategic alliances to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
    • 4.2.2 Rising of the Geriatric Population
    • 4.2.3 Technological Advancements in Coronary Stents
  • 4.3 Market Restraints
    • 4.3.1 High Product Recalls
    • 4.3.2 Stringent Approval Process for Stents
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Drug Eluting Stent
    • 5.1.2 Bare Metal Coronary Stent
    • 5.1.3 Bioabsorbable Stent
  • 5.2 By Biomaterial
    • 5.2.1 Metallic Biomaterial
    • 5.2.2 Polymeric Biomaterial
    • 5.2.3 Natural Biomaterial
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Ambulatory Surgical Centre
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 B. Braun Medical Inc.
    • 6.1.3 Biosensors International Group, Ltd.
    • 6.1.4 BIOTRONIK SE & Co. KG
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 Cook Medical Technologies
    • 6.1.7 Medtronic PLC
    • 6.1.8 Terumo Corporation
    • 6.1.9 Translumina GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS